Patents by Inventor Nelson Levy

Nelson Levy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8822500
    Abstract: The present disclosure relates to the field of tyrosine kinase enzyme inhibition, in particular anaplastic lymphoma kinase (ALK) inhibition using novel small molecules. Provided are compounds capable to modulate ALK activity, compositions that comprise the compounds, and methods of using the compounds for the treatment or prevention of diseases or conditions that are characterized by ALK activity or expression.
    Type: Grant
    Filed: September 13, 2011
    Date of Patent: September 2, 2014
    Assignee: Chembridge Corporation
    Inventor: Nelson Levy
  • Patent number: 8686005
    Abstract: Provided are compounds of the formula (I): or a stereoisomer, tautomer, salt, hydrate or prodrug thereof that modulate tyrosine kinase activity, compositions comprising the compounds and methods of their use.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: April 1, 2014
    Assignee: Chembridge Corporation
    Inventor: Nelson Levy
  • Publication number: 20120071473
    Abstract: Provided are compounds of the formula (I): or a stereoisomer, tautomer, salt, hydrate or prodrug thereof that modulate tyrosine kinase activity, compositions comprising the compounds and methods of their use.
    Type: Application
    Filed: September 23, 2011
    Publication date: March 22, 2012
    Inventors: Vlad Edward Gregor, Nelson Levy
  • Publication number: 20120065233
    Abstract: The present disclosure relates to the field of tyrosine kinase enzyme inhibition, in particular anaplastic lymphoma kinase (ALK) inhibition using novel small molecules. Provided are compounds capable to modulate ALK activity, compositions that comprise the compounds, and methods of using the compounds for the treatment or prevention of diseases or conditions that are characterized by ALK activity or expression.
    Type: Application
    Filed: September 13, 2011
    Publication date: March 15, 2012
    Inventors: Vlad Edward GREGOR, Nelson Levy
  • Publication number: 20060134758
    Abstract: Said process used to obtain, in industrial scale, wet sheets and membranes of bacterial cellulose of high purity and specific physical and chemical properties, using the appropriate culture medium that is prepared in a mechanical mixer furnished with a jacket for temperature control and heat exchange, using selected recycled or non-recycled inoculums, fermentation in covered trays with the temperature controlled by an external heating/cooling jacket through the circulation of hot/cold water, not requiring control of humidity and air renovation, collecting of the wet sheets that are then submitted to a process of purification and whitening by successive whirlpool washing and rinsing cycles using diverse heated or non-heated aqueous solutions, being afterwards forwarded to draining and drying/dehydration, passing through a semi-continuous system of rollers and belt conveyors made of absorbent material. This invention also refers to the process used to obtain compounded cellulosic wet sheets.
    Type: Application
    Filed: November 26, 2003
    Publication date: June 22, 2006
    Inventors: Nelson Levy, Edna Kurokawa, Pablo Podlech